When does canakinumab's patent expire?

When does canakinumab’s patent expire?

The exact patent-expiry date for canakinumab depends on which specific patent (and which country) you mean, because drug exclusivity is handled through a mix of patents and regulatory protections that can expire at different times.

For a consolidated view of canakinumab’s patent landscape and likely expiry dates, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/patent/Canakinumab

Does patent expiry mean the drug can be copied immediately?

No. Even after relevant patents expire, additional protections can delay market entry, such as other listed patents (method-of-use, formulation, etc.) and country-specific exclusivity periods. That means “patent expiry” and “first potential generic/biosimilar launch” are not always the same date.

What should you check to get the right expiry date?

To pinpoint the right expiry date for canakinumab, you typically need the jurisdiction (for example, US vs. EU) and the particular patent family being enforced (brand name products often have multiple patents with staggered timelines). DrugPatentWatch.com tracks these by patent listing and expiry timing, which helps match the date to the correct legal protection.